The newly purchased equipment in China is not as good as the old equipment in foreign countries, and the accuracy is far less than that of foreign countries.075%. In 2019, driven by the policies of “4 + 7” volume procurement, centralized procurement and expansion, in order to ensure production capacity
, the requirements of equipment manufacturing needle assembly machine and other requirements of the winning pharmaceutical companies may increase, and domestic pharmaceutical equipment companies are facing great opportunities And challenges, it needs to be arranged according to the requirements of pharmaceutical companies. There is no act of cutting corners. Various import substitution space Based on the above-mentioned gap, domestic pharmaceutical equipment companies are now making continuous efforts to narrow the gap.
Compared with foreign material standards, domestic standards are significantly lower. Foreign countries are more rigorous, especially the manufacturing powers of Germany and Japan are very rigorous about the equipment manufacturing process, and they are treated with the spirit of craftsmen. This is mainly because some parts of domestic equipment depend on imports for a long time and are expensive. It is designed and constructed with modular design, and it has the functions of pasteurization, low pressure circulation and dual water supply.
The relevant person in charge of the company said that after the implementation of the volume procurement policy, system intelligence will be the mainstream trend of pharmaceutical production in the future, and the construction standards of some pharmaceutical factories will be more intelligent, and the trend of fewer and unmanned, These are inseparable from the overall planning and consideration. Many equipment manufacturers can only purchase domestic ones, but it is not difficult to guarantee their processing level.
https://www.syringeassemblymachine.com/product/infusion-group-installed-series/sq-65-assembly-machine-for-inserting-bottle-needle-of-infusion-device.html
, the requirements of equipment manufacturing needle assembly machine and other requirements of the winning pharmaceutical companies may increase, and domestic pharmaceutical equipment companies are facing great opportunities And challenges, it needs to be arranged according to the requirements of pharmaceutical companies. There is no act of cutting corners. Various import substitution space Based on the above-mentioned gap, domestic pharmaceutical equipment companies are now making continuous efforts to narrow the gap.
Compared with foreign material standards, domestic standards are significantly lower. Foreign countries are more rigorous, especially the manufacturing powers of Germany and Japan are very rigorous about the equipment manufacturing process, and they are treated with the spirit of craftsmen. This is mainly because some parts of domestic equipment depend on imports for a long time and are expensive. It is designed and constructed with modular design, and it has the functions of pasteurization, low pressure circulation and dual water supply.
The relevant person in charge of the company said that after the implementation of the volume procurement policy, system intelligence will be the mainstream trend of pharmaceutical production in the future, and the construction standards of some pharmaceutical factories will be more intelligent, and the trend of fewer and unmanned, These are inseparable from the overall planning and consideration. Many equipment manufacturers can only purchase domestic ones, but it is not difficult to guarantee their processing level.
https://www.syringeassemblymachine.com/product/infusion-group-installed-series/sq-65-assembly-machine-for-inserting-bottle-needle-of-infusion-device.html
コメント